€40.56
2.31% day before yesterday
Xetra, Sep 06, 05:35 pm CET
ISIN
DE0005659700
Symbol
EUZ
Index
Sector

Eckert & Ziegler Strahlen- und Medizintechnik Stock price

€40.56
-0.44 1.07% 1M
+2.36 6.18% 6M
-0.74 1.79% YTD
+8.64 27.07% 1Y
-89.34 68.78% 3Y
-4.84 10.66% 5Y
+34.82 606.85% 10Y
Xetra, Closing price Fri, Sep 06 2024
-0.96 2.31%
ISIN
DE0005659700
Symbol
EUZ
Index
Sector

Key metrics

Market capitalization €845.49m
Enterprise Value €825.32m
P/E (TTM) P/E ratio 25.28
EV/FCF (TTM) EV/FCF 36.42
EV/Sales (TTM) EV/Sales 3.02
P/S ratio (TTM) P/S ratio 3.09
P/B ratio (TTM) P/B ratio 3.42
Dividend yield 0.12%
Last dividend (FY23) €0.05
Revenue growth (TTM) Revenue growth 17.18%
Revenue (TTM) Revenue €273.50m
EBIT (operating result TTM) EBIT €63.61m
Free Cash Flow (TTM) Free Cash Flow €22.66m
Cash position €76.63m
EPS (TTM) EPS €1.60
P/E forward 23.18
P/S forward 3.01
EV/Sales forward 2.94
Show more

Is Eckert & Ziegler Strahlen- und Medizintechnik a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Eckert & Ziegler Strahlen- und Medizintechnik Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Eckert & Ziegler Strahlen- und Medizintechnik:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Eckert & Ziegler Strahlen- und Medizintechnik:

Buy
100%

Financial data from Eckert & Ziegler Strahlen- und Medizintechnik

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
274 274
17% 17%
100%
- Direct Costs 142 142
14% 14%
52%
132 132
21% 21%
48%
- Selling and Administrative Expenses 55 55
11% 11%
20%
- Research and Development Expense - -
-
-
77 77
30% 30%
28%
- Depreciation and Amortization 14 14
19% 19%
5%
EBIT (Operating Income) EBIT 64 64
33% 33%
23%
Net Profit 33 33
35% 35%
12%

In millions EUR.

Don't miss a Thing! We will send you all news about Eckert & Ziegler Strahlen- und Medizintechnik directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Eckert & Ziegler Strahlen- und Medizintechnik Stock News

EQS
18 days ago
Berlin, 20.08.2024. In Anwesenheit der sächsischen Staatsminister Martin Dulig und Thomas Schmidt sowie des Dresdner Oberbürgermeisters Dirk Hilbert hat das Medizintechnikunternehmen Eckert & Ziegler heute mit rund 200 Gästen seine neuen, 1.700 qm großen Betriebsgebäude in Dresden eingeweiht. Am ...
EQS
26 days ago
Berlin, 13. August 2024 - Eckert & Ziegler und Telix Pharmaceuticals Limited (Telix) gaben heute die Unterzeichnung eines bedeutenden Mehrjahresvertrages bekannt, in dessen Rahmen Eckert & Ziegler als europäischer Auftragshersteller (CMO) für Telix' ProstACT GLOBAL Phase III Studie fungieren wird...
EQS
30 days ago
Die Umsätze im Segment Medical lagen in den ersten sechs Monaten des Jahres mit 69,7 Mio. € rund 17,1 Mio. € oder 32% über dem Niveau des Vorjahres. Hauptwachstumstreiber war nach wie vor das Geschäft mit pharmazeutischen Radioisotopen; auch die Umsätze im Bereich Anlagenbau konnten im Vergleich ...
More Eckert & Ziegler Strahlen- und Medizintechnik News

Company Profile

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Radiation Therapy, Isotope Products, and Radiopharma. The Radiation Therapy segment includes the production and distribution of medical products for the treatment of cancer using brachytherapy. The Isotope Products segment manufactures and distributes sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment is specialized in the field of molecular imaging and nuclear medicine, supplying different radiopharmaceuticals, radiochemicals and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.

Head office Germany
CEO Harald Hasselmann
Employees 1,075
Founded 1997
Website www.ezag.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today